Table 2.
Indication, Timing, and Outcome of High Lamotrigine and Levetiracetam Serum/Plasma Drug Levels.
| Lamotrigine level | Levetiracetam level | |
|---|---|---|
| > 14 mg/L | ≥ 80 mg/L | |
| (n = 597) | (n = 134) | |
| n (%) | n (%) | |
| Indication for Ordering Specific Drug Level | ||
| Documented overdose (intentional or accidental) | 34 (5.7 %) | 3 (2.2 %) |
| Routine check (not related to pregnancy) | 286 (47.9 %) | 54 (40.3 %) |
| Routine check pregnancy or post-partum | 10 (1.7 %) | 0 (0.0 %) |
| Seizures | 16 (2.7 %) | 4 (3.0 %) |
| Possible symptoms of drug toxicity | 200 (33.5 %) | 58 (43.3 %) |
| Unknown | 51 (8.5 %) | 15 (11.2 %) |
| Timing of level | ||
| Peak | 6 (1.0 %) | 1 (0.7 %) |
| Trough | 7 (1.2 %) | 0 (0.0 %) |
| Other specific timing | 6 (1.0 %) | 1 (0.7 %) |
| Random/unknown | 578 (96.8 %) | 132 (98.5 %) |
| Changes in Drug Dosing | ||
| Decreased, temporarily held, or discontinued maintenance dose | 172 (28.8 %) | 22 (16.4 %) |
| Maintained maintenance dose | 273 (45.7 %) | 51 (38.1 %) |
| Increased maintenance dose | 27 (4.5 %) | 2 (1.5 %) |
| Unknown | 125 (20.9 %) | 59 (44.0 %) |